Aflac (AFL)
(Delayed Data from NYSE)
$104.71 USD
-0.08 (-0.08%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $104.72 +0.01 (0.01%) 7:58 PM ET
2-Buy of 5 2
C Value F Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$104.71 USD
-0.08 (-0.08%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $104.72 +0.01 (0.01%) 7:58 PM ET
2-Buy of 5 2
C Value F Growth A Momentum D VGM
Zacks News
Aflac (AFL) Q1 Earnings Beat on Margin Growth, View Intact
by Zacks Equity Research
Aflac (AFL) Q1 earnings gain from stronger yen/dollar exchange rate, favorable pretax margins and a lower effective tax rate.
Can Marsh & McLennan (MMC) Q1 Earnings Beat on Revenues?
by Zacks Equity Research
Higher revenues backed by a solid segmental performance might aid Marsh & McLennan (MMC) to beat on earnings in Q1.
Hartford Financial (HIG) Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Strong segmental performances are likely to drive Hartford Financial's (HIG) first-quarter earnings.
Can Discover Financial (DFS) Q1 Earnings Beat on Card Sales?
by Zacks Equity Research
Discover Financial's (DFS) first quarter results are likely to be impacted by solid card sales and segmental performance.
The Zacks Analyst Blog Highlights: Aflac, CenterPoint, Guess', Nordstrom and Pfizer
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Aflac, CenterPoint, Guess', Nordstrom and Pfizer
Is a Beat in Cards for Nasdaq (NDAQ) This Earnings Season?
by Zacks Equity Research
Better performance in Market Services segment, improved non-transaction revenues as well as higher volumes are likely to drive Nasdaq's (NDAQ) Q1 earnings.
Why Earnings Season Could Be Great for Aflac (AFL)
by Zacks Equity Research
Aflac (AFL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Aflac (AFL) Q1 Earnings to Gain From Higher US Segment Sales
by Zacks Equity Research
Aflac (AFL) Q1 earnings should see an upside from sales growth in its U.S. segment, partly offset by soft sales in the Japan segment.
American Express' (AXP) Billings, Loans to Aid Q1 Earnings
by Zacks Equity Research
American Express Company (AXP) results should see upside from accelerated growth in billings and continued strong growth in loans and fees.
Should You Get Rid of Amerisafe (AMSF) Now?
by Zacks Equity Research
It seems to be a wise decision for investors to drop Amerisafe (AMSF) stock considering its negative estimate revision, price depreciation as well as unfavorable Zacks rank.
The Zacks Analyst Blog Highlights: Oracle, Vale, General Mills, Aflac and Mylan
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Oracle, Vale, General Mills, Aflac and Mylan
5 Factors That Make Aflac (AFL) an Attractive Bet for Now
by Zacks Equity Research
Aflac's (AFL) strong U.S. business, benefits from tax reform, capital strength and strong earnings projection make it an attractive pick for investors.
Amerisafe's (AMSF) Q4 Earnings Miss as Revenues Decline
by Zacks Equity Research
Amerisafe's (AMSF) earnings suffer from a decline in revenues and increase in expenses.
Solid Q4 Earnings Drive Insurance ETFs Outlook
by Sweta Killa
Although insurance ETFs have witnessed terrible trading over the past month due to global market rout, robust Q4 results reinvigorated confidence in the space.
The Zacks Analyst Blog Highlights: Broadcom, Canadian National, CVS Health, Aflac and DXC Technolog
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Broadcom, Canadian National, CVS Health, Aflac and DXC Technolog
Company News For Feb 2, 2018
by Zacks Equity Research
Companies In The News are: T,DWDP.AFL,SYMC
Lincoln National (LNC) Beats on Q4 Earnings and Revenues
by Zacks Equity Research
Lincoln National's (LNC) earnings gain from higher premium and fee income, partly offset by high expenses.
Aflac's (AFL) Q4 Earnings Surpass Expectations, Improve Y/Y
by Zacks Equity Research
Aflac's (AFL) strong fourth-quarter results are driven by solid performance of its U.S. segment.
Insurers Reporting Q4 Earnings on Jan 31: AFL, LNC, UNM
by Zacks Equity Research
Insurers' fourth-quarter results are likely to be impacted by catastrophic events, improving interest rate environment and a booming U.S economy.
Will Weak Japan Business Hurt Aflac's (AFL) Q4 Earnings?
by Zacks Equity Research
Aflac's (AFL) earnings should see a dent from weak Japan business but be partially aided by strength in its U.S. business.
Aflac (AFL) Hits New 52-Week High: Is More Upside Left?
by Zacks Equity Research
Aflac (AFL) gains on estimated positive impact of tax reform but further upside seems muted.
Aflac (AFL) to Invest $250 Million Post Tax Bill Enactment
by Zacks Equity Research
Aflac (AFL) commits to invest $25 million for growth led by favorable impact of the new tax regime.
Should Value Investors Consider Aflac Incorp. (AFL) Stock?
by Zacks Equity Research
Let's put Aflac Incorporated (AFL) stock into this equation and find out if it is a good choice for value-oriented investors right now.
AIG Misses on Q3 Earnings Due to Weather, to Puff Up Reserves
by Zacks Equity Research
AIG's third-quarter earnings suffered from catastrophe losses, partly offset by reduction in expense.
Aflac (AFL) Earnings Beat Estimates in Q3, Revenues Miss
by Zacks Equity Research
Aflac (AFL) witnesses a year-over-year decline in third-quarter earnings due to weakening of yen.